Showing results (1211-1220 of 1,689) with videos related to

Sort By:
Pageof 169
European Journal of Heart Failure|March 2, 2026
Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trialMisato Chimura, Pardeep S Jhund, Alasdair D Henderson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2015
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)David M Charytan, Eldrin F Lewis, Akshay S Desai, et al.
European Journal of Heart Failure|May 1, 2020
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, Alice Jackson, Pardeep S Jhund, et al.
European Journal of Heart Failure|July 29, 2020
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERESøren Lund Kristensen, Davide Castagno, Li Shen, et al.
American Heart Journal|October 11, 2011
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)John J V McMurray, Hajime Uno, Petr Jarolim, et al.
ESMO Open|March 15, 2025
The impact of co-occurring tumor suppressor mutations with mEGFR as early indicators of relapse in lung cancerS Hait, V Noronha, A Chowdhury, et al.
JACC. Heart Failure|October 10, 2024
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF TrialsHenri Lu, Brian L Claggett, Milton Packer, et al.
Cells|March 6, 2021
Oligomeric Aβ1-42 Induces an AMD-Like Phenotype and Accumulates in Lysosomes to Impair RPE FunctionSavannah A Lynn, David A Johnston, Jenny A Scott, et al.
Lancet (London, England)|August 30, 2022
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trialsMuthiah Vaduganathan, Kieran F Docherty, Brian L Claggett, et al.
European Heart Journal|November 8, 2024
Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trialsSimon Wandel, Akshay S Desai, Chien-Wei Chen, et al.
Pageof 169